We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

193 hedge funds and large institutions have $3.92B invested in Dyne Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 79 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

527% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $973K

124% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 21

72% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 46

45% more capital invested

Capital invested by funds: $2.71B → $3.92B (+$1.21B)

40% more funds holding in top 10

Funds holding in top 10: 10 → 14 (+4)

14% more funds holding

Funds holding: 169 → 193 (+24)

3.01% less ownership

Funds ownership: 116.41% → 113.4% (-3%)

Holders
193
Holders Change
+24
Holders Change %
+14.2%
% of All Funds
2.79%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.2%
New
47
Increased
79
Reduced
46
Closed
21
Calls
$6.11M
Puts
$973K
Net Calls
+$5.13M
Net Calls Change
+$11.2M

Top Buyers

1
RI
RTW Investments
New York
+$95.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$61M
3
Holocene Advisors
Holocene Advisors
New York
+$60.3M
4
BlackRock
BlackRock
New York
+$58M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$56.6M

Top Sellers

1
MAM
MPM Asset Management
Massachusetts
-$54.9M
2
LGM
Logos Global Management
California
-$42.6M
3
State Street
State Street
Massachusetts
-$28.8M
4
DTC
Deep Track Capital
Connecticut
-$16.1M
5
NCM
Nantahala Capital Management
Connecticut
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
176
Lindbrook Capital
California
$11.4K +$5.32K +183 +130%
AAP
177
Arax Advisory Partners
Colorado
$8.82K +$581 +20 +9%
QCG
178
Quadrant Capital Group
Ohio
$8.15K – – –
GI
179
GAMMA Investing
California
$6.92K +$523 +18 +10%
Comerica Bank
180
Comerica Bank
Texas
$6.18K – – –
US Bancorp
181
US Bancorp
Minnesota
$5.5K – – –
FHA
182
First Horizon Advisors
Tennessee
$5.4K +$4.45K +153 New
WTA
183
Washington Trust Advisors
Massachusetts
$4.41K – – –
IC
184
Innealta Capital
Texas
$2.86K +$2.35K +81 New
BAM
185
Bellevue Asset Management
Washington
$1.66K – – –
Osaic Holdings
186
Osaic Holdings
Arizona
$1.62K -$940K -32,364 -100%
RIL
187
Rothschild Investment LLC
Illinois
$1.24K +$872 +30 +600%
SAM
188
Smartleaf Asset Management
Massachusetts
$1.13K +$930 +32 New
PNC Financial Services Group
189
PNC Financial Services Group
Pennsylvania
$1.02K +$552 +19 +190%
PA
190
Parallel Advisors
California
$953 +$785 +27 New
AF
191
Allworth Financial
California
$208 +$145 +5 New
HT
192
Headlands Technologies
Illinois
$35 -$7.41K -255 -100%
NCM
193
Nantahala Capital Management
Connecticut
– -$12.4M -435,256 Closed
Qube Research & Technologies (QRT)
194
Qube Research & Technologies (QRT)
United Kingdom
– -$2.86M -100,656 Closed
SCM
195
Superstring Capital Management
New York
– -$2.83M -99,822 Closed
CSS
196
Cubist Systematic Strategies
Connecticut
– -$1.22M -42,817 Closed
AIG
197
American International Group
New York
– -$827K -29,138 Closed
JF
198
Jump Financial
Illinois
– -$777K -27,382 Closed
MG
199
Marex Group
– -$724K -25,500 Closed
Capstone Investment Advisors
200
Capstone Investment Advisors
New York
– -$575K -20,248 Closed
5 6 7
8
9

DYN Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2024, worth a combined $3.92B — up 45% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new DYN positions and 21 closed out — a net gain of 26 holders — while 79 added to existing stakes and 46 trimmed.

The largest buyer was RTW Investments, adding an estimated $95.8M. The largest seller was MPM Asset Management, cutting an estimated $54.9M.

  • 193 institutional investors held Dyne Therapeutics (DYN) as of Q2 2024, up from 169 in Q1 2024.
  • Funds reported $3.92B of Dyne Therapeutics stock for Q2 2024, up 45% quarter-over-quarter.
  • 47 funds opened new Dyne Therapeutics positions in Q2 2024 and 21 closed out, a net change of +26 holders.
  • The largest Dyne Therapeutics buyer in Q2 2024 was RTW Investments, an estimated $95.8M added.
  • The largest Dyne Therapeutics seller in Q2 2024 was MPM Asset Management, an estimated $54.9M sold.

Based on aggregated 13F filings for Q2 2024.